Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1927-2021Class II

Case Cardiac Assessment System for Exercise Testing and CardioSoft Diagnostic System Exercise Stress Testing...

GE Healthcare / initiated 2021-04-19 / Terminated / root cause: software

GE Healthcare, LLC began a recall of Case Cardiac Assessment System for Exercise Testing and CardioSoft Diagnostic System Exercise Stress Testing ECG application on . FDA classified it as Class II and gives the reason as "If a certain sequence of events occur, the pdf test report that belongs to one patient will appear in a different patient's record when viewed in an Electronic Medical Record (EMR) or a similar system". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-1927-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
GE Healthcare
Product
Case Cardiac Assessment System for Exercise Testing and CardioSoft Diagnostic System Exercise Stress Testing ECG application
Product code
DQK Computer, Diagnostic, Programmable
Reason for recall
If a certain sequence of events occur, the pdf test report that belongs to one patient will appear in a different patient's record when viewed in an Electronic Medical Record (EMR) or a similar system.
Root cause tag
software
FDA root cause
Software design
Action
The recalling firm issued letters dated 4/19/2021 beginning 4/19/2021. For systems that are on Windows 8.1 and above, the issue will be corrected through a software patch. For the units running on Microsoft Windows Server 2008-R2, Windows XP, and Windows 7, the letter instructs that the devices are not to be networked on these systems and that a software patch cannot be made available to these systems since the operating systems are not supported by Microsoft. A second cover letter and customer notification were issued dated 5/10/2021 updating the second safety instruction regarding the units running on Microsoft Windows Server 2008-R2, Windows XP, and Windows 7 saying that these systems must be rebooted before manually exporting tests.
Quantity in commerce
11,295 devices (5,637 US; 5,658 OUS)
Distribution
Worldwide distribution - US Nationwide. Government/military distribution was also made, and the countries of Algeria, Argentina, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Belgium, Bermuda, Brazil, Brunei Darussalam, Cambodia, Canada, Cayman Islands, Chile, China, Colombia, Costa Rica, Curacao, Cyprus, Czech Republic, Czechia, Denmark, Estonia, Fiji, Finland, France, Germany, Greece, Honduras, Hong Kong, Hungary, India, Indonesia, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Republic of Korea, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Malta, Mexico, Moldova, Myanmar, Netherlands, New Zealand, Norway, Oman, Panama, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russia, Russian Federation, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Arab Emirates, United Kingdom, Uruguay, and Viet Nam.
Product codes and lots
CASE and CardioSoft - v6.6x, v6.7x and v7.0

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1927-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1927-2021Class IITerminatedVoluntary: Firm initiated